Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial
02 mai 2024 08h00 HE
|
Science 37, Inc.
Science 37's Metasite™ and Patient Recruitment Solutions together dramatically boost patient enrollment in a Phase 3 asthma clinical trial.
Asthma Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - GlaxoSmithKline, AstraZeneca, 4D Pharma plc, Suzhou Connect Biopharmaceuticals, and Others
27 mars 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, March 27, 2023 (GLOBE NEWSWIRE) -- Asthma Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - GlaxoSmithKline, AstraZeneca, 4D Pharma plc, Suzhou...
Nuvaira Announces 1st Patient Treated in RELIEF-1 Study Evaluating New Approach for Asthma Treatment
27 mars 2018 08h00 HE
|
Nuvaira, Inc.
MINNEAPOLIS, March 27, 2018 (GLOBE NEWSWIRE) -- Nuvaira, a developer of medical devices to treat obstructive lung diseases, today announced treatment of the first patient in the RELIEF-1 Clinical...